Seeking Alpha

Allergan Inc. (AGN)

()

News & PR
Market Currents

Buzz
Twitter: AGN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Wall Street Breakfast: Must-Know News

Oct 29 • SA Editor Eli Hoffmann • 15 Comments
Earnings Preview: Allergan

Oct 28 • theflyonthewall.com • Comment!
Galleon Group's 50 Largest Holdings

Oct 18 • AlphaClone • 10 Comments
On Small Cap Drug Makers and Volatility

Oct 18 • Justin M. Hall • 6 Comments
11 Ache-Free Investment Opportunities in Neuropathic Pain

Sep 30 • Michael Becker • 1 Comment
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Eton Park Loads Up on Options

Sep 2 • Market Folly • 3 Comments
Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist

Aug 10 • Justin M. Hall • 24 Comments
Who Will Buy Spectrum Pharmacueticals?

Aug 6 • Mark Cifra • 2 Comments
Tracking Healthcare Trends and More

Aug 5 • Mike Havrilla • 3 Comments
Allergan Rumors Are Nothing to Sneeze At

Aug 4 • optionMONSTER • Comment!
FDA Calendar Updates: STAAR Surgical, Spectrum Pharma, Allergan, Incyte, Ardea

Jul 21 • Mike Havrilla • Comment!
A Look at the Neural Fair Value Portfolio for Investment Ideas

Jun 24 • Thomas Smicklas • Comment!
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline

Jun 19 • Justin M. Hall • 19 Comments
Amgen's Better than Expected Portfolio Outlook

Jun 18 • Vincent Fernando • 1 Comment
15 Stocks with the Stamina to Survive This Crisis

Jun 17 • J Clinton Hill • 4 Comments
FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM

May 29 • Mike Havrilla • 3 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly

May 27 • Mark Cifra • 4 Comments
Hedge Fund Eton Park Saw Golden Opportunities in Q109

May 27 • Market Folly • 2 Comments
Inspire Pharma Still Looks Good After Earnings

May 14 • Zacks.com • Comment!
20 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week

May 4 • J Clinton Hill • 2 Comments
FDA Calendar Updates: Botox Rival Approved

May 3 • Mike Havrilla • Comment!
Preview from Europe: Stocks Encounter Car Trouble

May 1 • The Mole • 2 Comments
Thursday Options Recap

Apr 23 • Frederic Ruffy • 1 Comment
Thursday Options Update: VMW, FXI, AGN, WYE, XRT & COH

Apr 23 • Andrew Wilkinson • Comment!
Paired Trade: Sell Allergan, Buy Johnson & Johnson

Apr 18 • Alan Brochstein • 5 Comments
Updated FDA, Clinical Trial Calendars: Dendreon Releases Results

Apr 15 • Mike Havrilla • Comment!
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500

Apr 13 • Don Dion • 1 Comment
Morphosys: A Biotech Rule Breaker (Part 2)

Mar 30 • Ohad Hammer • Comment!
Tuesday Options Update: Q, AGN, VIX, LTD, XHB, SYK, IP & TGT

Mar 24 • Andrew Wilkinson • Comment!
Monday Options Update: XLF, JPM, C, AGN, RHT, SU, SWY

Mar 23 • Andrew Wilkinson • Comment!
Earnings Preview: Allergan

Feb 3 • theflyonthewall.com • Comment!
Cynosure Has Weak Q4, Sparking Possibilities of Takeover

Jan 19 • Mike Havrilla • Comment!
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008

Jan 15 • Market Folly • Comment!
Updated FDA Decision Calendar: Five Decisions Before Year-End

Dec 28, 2008 • Mike Havrilla • 10 Comments
Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008

Dec 11, 2008 • Market Folly • 1 Comment
Johnson & Johnson Steals Mentor Corp.: Who's Next?

Dec 8, 2008 • Daniel Andres Jacome • 8 Comments
Weekly FDA Calendar Update

Dec 7, 2008 • Mike Havrilla • Comment!
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?

Nov 10, 2008 • Ohad Hammer • 2 Comments
Earnings Preview: Allergan

Oct 28, 2008 • theflyonthewall.com • Comment!

Allergan Inc. (AGN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers